Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease

JAMA. 2009 Mar 25;301(12):1223; author reply 1225-6. doi: 10.1001/jama.2008.947.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Cholinergic Antagonists / adverse effects*
  • Humans
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Risk
  • Scopolamine Derivatives / adverse effects*
  • Tiotropium Bromide

Substances

  • Cholinergic Antagonists
  • Scopolamine Derivatives
  • Tiotropium Bromide